Hologic, Inc. (HOLX) was upgraded to a Buy recommendation by TheStreet.com's quantitative service today. I decided to look at the charts of this developer and manufacturer of diagnostic medical products to see if the charts and the quantitative story were in alignment.
More from Investing
It's dangerous to have too much exposure now, but the potential for a good recovery is there once interest rate issues are digested.
While the Chinese company is still not profitable, it is cash flow positive.
Here's what investors and traders need to think about.
I've added a few names that I see as a great risk-reward because of the limited downside.